Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products

被引:54
作者
El-Gindy, A [1 ]
El-Yazby, F
Maher, MM
机构
[1] Suez Canal Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Ismailia 41522, Egypt
[2] Univ Alexandria, Fac Pharm, Dept Pharmaceut Analyt Chem, Alexandria, Egypt
[3] Pharaonia Pharmaceut, New Borg El Arab City, Alexandria, Egypt
关键词
rabeprazole; HPLC; HPTLC-densitometry; first derivative of the ratio spectra; kinetics of degradation; pH-rate profile; arrhenius plot;
D O I
10.1016/S0731-7085(02)00445-4
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Three methods were presented for the determination, of rabeprazole (RA) in presence of its degradation products. The first method was based on high performance liquid chromatographic (HPLC) separation of RA from its degradation products on a reversed phase, ODS column using a mobile phase of methanol-water (70:30, v/v) and UV detection at 284 nm. The second method was based on HPTLC separation followed by densitometric measurement of the spots at 284 nm. The separation was carried out on Merck HPTLC sheets of silica gel 60 F 254, using acetone-toluene -methanol (9:9:0.6 v/v) as mobile phase. The third method depends on first derivative of the ratio spectra ((DD)-D-1) by measurement of the amplitudes at 310.2 nm. Moreover, the proposed HPLC method was utilized to investigate the kinetics of the oxidative and photo degradation processes. The pH-rate profile of degradation of RA in Britton-Robinson buffer solutions within the pH range 3-11 was studied. In addition, the activation energy of RA degradation was calculated in Britton-Robinson buffer solution pH 7. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:229 / 242
页数:14
相关论文
共 15 条
[1]  
[Anonymous], POLAROGRAPHY MED BIO
[2]  
DIAMOND D, 1997, SPREADSHEET APPL CHE, P47
[3]  
*EUR AG EV MED PRO, 1996, ICH TOP Q 2B NOT GUI
[4]  
Fried B., 1994, THIN LAYER CHROMATOG
[5]   A contribution to the derivative ratio spectrum method [J].
Garcia, JM ;
Hernandez, O ;
Jimenez, AI ;
Jimenez, F ;
Arias, JJ .
ANALYTICA CHIMICA ACTA, 1995, 317 (1-3) :83-93
[6]  
*ICH STAB TEST NEW, 1993, INT C HARM GEN OCT
[7]   Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography [J].
McCarthy, KE ;
Wang, QX ;
Tsai, EW ;
Gilbert, RE ;
Ip, DP ;
Brooks, MA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (4-5) :671-677
[8]   SIMULTANEOUS DETERMINATION OF CEFTRIAXONE AND STREPTOMYCIN IN MIXTURE BY RATIO-SPECTRA 2ND DERIVATIVE AND ZERO-CROSSING 3RD DERIVATIVE SPECTROPHOTOMETRY [J].
MORELLI, B .
TALANTA, 1994, 41 (05) :673-683
[9]  
MUNSON JW, 1984, PHARMACEUTICAL ANA B, P166
[10]   DETERMINATION OF A NEW H+-K+ ATPASE INHIBITOR (E3810) AND ITS 4 METABOLITES IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
NAKAI, H ;
SHIMAMURA, Y ;
KANAZAWA, T ;
YASUDA, S ;
KAYANO, M .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 660 (01) :211-220